| Catalog | name | Description | price |
|---|---|---|---|
| R-C-4222 | DSPE-PEG350-NOTA | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy](sodium salt)is a PEG-modified lipids. It is a long circulating liposome membrane,formation of micelles in water dispersion,the critical micelle concentration(CMC)ratio of surfactant is 102 times lower,so the drug stability is better, even by hemodilution,can maintain the integrity of the micelle particle,has certain targeting,easy accumulation in solid tumors.Suitable for the development of long circulating liposomes.NOTA is a triaza macrocyclic ligand that has shown to have potential to act as scintigraphic and PET(Positron Emission Tomog)imaging agents. | price> |
| R-C-4223 | DSPE-polyethylene glycol550-NOTA | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy](sodium salt)is a PEG-modified lipids. It is a long circulating liposome membrane,formation of micelles in water dispersion,the critical micelle concentration(CMC)ratio of surfactant is 102 times lower,so the drug stability is better, even by hemodilution,can maintain the integrity of the micelle particle,has certain targeting,easy accumulation in solid tumors.Suitable for the development of long circulating liposomes.NOTA is a triaza macrocyclic ligand that has shown to have potential to act as scintigraphic and PET(Positron Emission Tomog)imaging agents. | price> |
| R-C-4224 | NOTA-PEG750-DSPE | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy](sodium salt)is a PEG-modified lipids. It is a long circulating liposome membrane,formation of micelles in water dispersion,the critical micelle concentration(CMC)ratio of surfactant is 102 times lower,so the drug stability is better, even by hemodilution,can maintain the integrity of the micelle particle,has certain targeting,easy accumulation in solid tumors.Suitable for the development of long circulating liposomes.NOTA is a triaza macrocyclic ligand that has shown to have potential to act as scintigraphic and PET(Positron Emission Tomog)imaging agents. | price> |
| R-C-4225 | DSPE-PEG350-DOTA | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] (sodium salt) is a PEG-modified lipids. DOTA is a chelating agent. | price> |
| R-C-4226 | DSPE-polyethylene glycol550-DOTA | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] (sodium salt) is a PEG-modified lipids. DOTA is a chelating agent. | price> |
| R-C-4227 | DOTA-PEG750-DSPE | DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] (sodium salt) is a PEG-modified lipids. DOTA is a chelating agent. | price> |
| R-C-4228 | DSPE-PEG350-HA | DSPE-PEG-HA,1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-hyaluronic acid,DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] is a PEG-modified lipids.the Molecular Weight of Hyaluronate can choice 5000,10000,20000,50000Dalton. | price> |
| R-C-4229 | DSPE-polyethylene glycol550-HA | DSPE-PEG-HA,1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-hyaluronic acid,DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] is a PEG-modified lipids.the Molecular Weight of Hyaluronate can choice 5000,10000,20000,50000Dalton. | price> |
| R-C-4230 | hyaluronic acid-PEG750-DSPE | DSPE-PEG-HA,1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol-hyaluronic acid,DSPE-mPEG,1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[(polyethylene glycol)-methoxy] is a PEG-modified lipids.the Molecular Weight of Hyaluronate can choice 5000,10000,20000,50000Dalton. | price> |
| R-C-4231 | DSPE-PEG350-RDP | The brain targeting RDP was coupled with distearoyl phosphatidyl (DSPE-PEG-NHS) to prepare a targeting compound DSPE-PEG-RDP. Then RDP modified 2.2-bipyridyl ruthenium complex liposome modified by RDP and common 2.2-bipyridyl ruthenium complex liposomes were prepared by thin-film dispersion method. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


